Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · Real-Time Price · USD
19.28
+0.23 (1.21%)
At close: Dec 5, 2025, 4:00 PM EST
19.07
-0.21 (-1.09%)
After-hours: Dec 5, 2025, 6:19 PM EST
Sabra Health Care REIT Stock Forecast
Stock Price Forecast
The 9 analysts that cover Sabra Health Care REIT stock have a consensus rating of "Hold" and an average price target of $20.56, which forecasts a 6.64% increase in the stock price over the next year. The lowest target is $20 and the highest is $22.
Price Target: $20.56 (+6.64%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Sabra Health Care REIT stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 3 | 3 | 4 | 4 | 5 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 8 | 8 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $20 → $21 | Buy | Maintains | $20 → $21 | +8.92% | Nov 25, 2025 |
| UBS | UBS | Hold Initiates $20 | Hold | Initiates | $20 | +3.73% | Nov 18, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $21 → $20 | Buy | Maintains | $21 → $20 | +3.73% | Oct 21, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Initiates $20 | Hold | Initiates | $20 | +3.73% | Oct 1, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $18 → $20 | Hold | Maintains | $18 → $20 | +3.73% | Sep 3, 2025 |
Financial Forecast
Revenue This Year
756.74M
from 702.64M
Increased by 7.70%
Revenue Next Year
810.24M
from 756.74M
Increased by 7.07%
EPS This Year
0.76
from 0.54
Increased by 41.19%
EPS Next Year
0.79
from 0.76
Increased by 3.34%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 821.0M | 992.7M | ||||
| Avg | 756.7M | 810.2M | ||||
| Low | 692.7M | 550.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 16.8% | 31.2% | ||||
| Avg | 7.7% | 7.1% | ||||
| Low | -1.4% | -27.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.85 | 0.88 | |
| Avg | 0.76 | 0.79 | |
| Low | 0.69 | 0.72 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 57.5% | 15.7% | |
| Avg | 41.2% | 3.3% | |
| Low | 27.0% | -6.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.